AstraZeneca COVID-19 Antibody Could Be Solution For Vulnerable But Not Vaccine Alternative
Long-Acting Drug Filed With FDA
AZD7442 can provide antibodies in people who cannot generate their own after vaccination but could in theory also be used to protect other groups, including unvaccinated populations.
